TechnipFMC plc
—- Market cap
- —
- Debt
- +$464.30M
- Cash
- −$1.03B
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: FTI stock price vs DOCS: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at DOCS's multiple
Needs DOCS P/E.
Implied fair value · at FTI's multiple
Needs FTI P/E.
Metric by metric
Where each company leads, and how wide the gap is.
Price unavailable
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: FTI FY 2025 (ended Dec 31, 2025) · DOCS FY 2026 (ended Mar 31, 2026). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
TechnipFMC plc · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Doximity, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.14x
0.05x
Net debt / EBITDA
Leverage against operating earnings
-0.34x
-0.64x
Cash and equivalents
Liquid reserves on the balance sheet
$1.03B
$219.18M
Total debt
Interest-bearing obligations outstanding
$464.30M
$44.32M
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
SCHLUMBERGER LIMITED/NV
FTI vs SLB
Baker Hughes Co
FTI vs BKR
HALLIBURTON CO
FTI vs HAL
NOV Inc.
FTI vs NOV
Weatherford International plc
FTI vs WFRD
HEALTHEQUITY, INC.
FTI vs HQY
Teladoc Health, Inc.
FTI vs TDOC
Hims & Hers Health, Inc.
FTI vs HIMS
GoodRx Holdings, Inc.
FTI vs GDRX
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.